Project Grant HT94252510748

Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $2.4M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The federal Project Grant award of $319,624 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Oregon Health & Science University (OHSU) located in Portland, Oregon. The award supports advanced biomedical research aimed at investigating cell cycle regulators in oligodendrocyte myelination, which is relevant to transforming healthcare for military service members and the broader public. OHSU, a prominent academic...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
The federal Project Grant award of $391,743.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The award is for the development of a "compact, high resolution, 3D optical imager for anterior eye injury and disease." This research aims to advance innovative medical imaging technologies that can transform healthcare for military service members, veterans, and the...
This $1,000,000.00 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating whether the gut microbiome coordinates with the gut-brain axis to contribute to behavioral alterations and cognitive injuries following traumatic brain injury (TBI), and if these effects are more profound in individuals with the APOE E4 genetic variant. The prime...
The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
This Project Grant award of $395,134.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), will fund a collaborative pilot project between Oregon Health & Science University (OHSU) and the Warm Springs Tribe to address health disparities in the Native American population. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research focused...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
This Project Grant award of $1,401,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The funding will support a 3-year research project investigating the impact of recent childbirth on breast cancer prognosis and tumor molecular phenotypes among young Black and White women. The research aims to enhance understanding of breast cancer disease progression and outcomes in this...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $618,866.00 to Oregon Health & Science University (OHSU) to address health disparities in the Native American population through a pilot collaboration with the Warm Springs Tribe. The award is effective from September 29, 2024 through September 28, 2027. OHSU, a prominent academic medical center and research university, will...

The federal Project Grant award, with ID HT94252510748, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, totaling $2,358,273.00, will support research at Oregon Health & Science University (OHSU) from September 1, 2025, through August 31, 2029. The research aims to investigate postural motor activation deficits following mild traumatic brain injury (mTBI), with the goal of translating laboratory findings into clinical care. OHSU, a prominent academic medical center and research university, has a strong track record of delivering sophisticated medical research services to federal agencies, including the Department of Veterans Affairs. This grant award demonstrates the agency's commitment to advancing innovative biomedical research that can transform healthcare for military service members, veterans, and the broader public.

Generated 8/5/25, 6:30 AM